home / lobbying

lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

791 rows where filing_year = 2010 and issue_code = "PHA" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: filing_type, is_termination, received_date (date)

filing_period 4

  • first_quarter 218
  • second_quarter 199
  • fourth_quarter 188
  • third_quarter 186

issue_code 1

  • PHA · 791 ✖

filing_year 1

  • 2010 · 791 ✖
id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
907684 CYBER SECURITY RESEARCH CONSULTANTS, LLC 3a8799a1-391f-4316-94e1-e80ae8588cc0 Q1 CYBER SECURITY RESEARCH CONSULTANTS, LLC 91694 PDFRAZER CONSULTING INC CANADIAN INTERNATIONAL PHARMACY ASSOCIATION 2010 first_quarter PHA Food and Drug Safety Globalization Act Monitoring Dorgan-Snowe Drug reimportation from Canada Health Care Reform HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2010-04-01T09:24:37.463000-04:00
907715 MR. THEODORE (TED) JONES a7b616b5-31e1-43d7-86f4-a3c6524fd7f4 Q1 MR. THEODORE (TED) JONES 20926 PHARMACEUTICAL RESEARCH AND MANUFACTURES OF AMERICA 2010 first_quarter PHA Trade Association for certain Pharmaceutical Companies HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2010-04-01T13:25:01.870000-04:00
907930 HOLLAND & KNIGHT LLP a12f848b-864f-4b89-a2ab-485925ec7f3b Q1 HOLLAND & KNIGHT LLP 18466 AMERICAN SOCIETY OF HEMATOLOGY 2010 first_quarter PHA Hematology and Oncology drug research and approval issues. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 20000   0 0 2010-04-05T10:03:04.730000-04:00
907936 HOLLAND & KNIGHT LLP a67ac18b-af17-43f8-84d7-b4f08d8dbf35 Q1 HOLLAND & KNIGHT LLP 18466 NATIONAL HEMOPHILIA FOUNDATION 2010 first_quarter PHA Blood and blood product safety; issues related to blood product approvals. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 40000   0 0 2010-04-05T10:05:06.447000-04:00
907959 LONG TERM CARE PHARMACY ALLIANCE 9a4b09b4-d49d-433a-9ff7-8a28c580a9ca Q1 LONG TERM CARE PHARMACY ALLIANCE 400309443 LONG TERM CARE PHARMACY ALLIANCE 2010 first_quarter PHA Medicare Part D Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   201000 0 0 2010-04-05T11:26:28.947000-04:00
908464 UNIVERSITY OF IOWA d7d49f12-4f9b-4701-ab53-0962e58441a5 Q1 UNIVERSITY OF IOWA 49191 UNIVERSITY OF IOWA 2010 first_quarter PHA Increased appropriations for systems to shorten the time between development of a drug and its release to the public. FDA reform as it relates to drug development and research Collaborative research on drug development anti-malarial pharmaceuticals FY 2010 Agricultural Appropriations human factors research related to neuropharmaceuticals Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),Office of Science & Technology Policy (OSTP),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT)   110000 0 0 2010-04-07T10:00:52.507000-04:00
908566 PARRY, ROMANI, DECONCINI & SYMMS 08d890b8-9cce-44aa-a28a-cf112cee36c7 Q1 PARRY, ROMANI, DECONCINI & SYMMS 30792 AMERICAN ASSOCIATION FOR HEALTH FREEDOM 2010 first_quarter PHA Support of legislation and efforts to guarantee access by health professionals and patients to medications such as estriol and other compounded preparations. No specific legislation has been introduced yet. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2010-04-07T12:07:10.680000-04:00
908701 ACG ADVOCACY 45c26d54-edf7-4d9c-bcc5-382c191730d1 Q1 ACG ADVOCACY 2057 PFIZER, INC. 2010 first_quarter PHA Followon Biologics Super MedPAC HRSA - 340B Drug Pricing Program/Pharmacy Affairs HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2010-04-07T14:15:14.220000-04:00
908768 PARRY, ROMANI, DECONCINI & SYMMS a29595c0-da63-4947-9ce5-a1a0c8cff16a Q1 PARRY, ROMANI, DECONCINI & SYMMS 30792 BRAIDWOOD MANAGEMENT, INC. 2010 first_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. H.R. 3018, To amend the Controlled Substances Act to address the use of intrathecal pumps. Amends the Controlled Substances Act to revise the definition of "dispense" to include the delivery of a controlled substance through the use of an intrathecal pump by a practitioner acting in the usual course of professional practice. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2010-04-07T15:13:35.247000-04:00
908836 PARRY, ROMANI, DECONCINI & SYMMS 78263cf2-97d9-435c-ba81-cc6bac3d5f5e Q1 PARRY, ROMANI, DECONCINI & SYMMS 30792 VETERINARY PHARMACIES OF AMERICA, INC. 2010 first_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2010-04-07T16:14:56.623000-04:00
908838 PARRY, ROMANI, DECONCINI & SYMMS 9780379a-e9fd-4e55-b31b-11c795f2d573 Q1 PARRY, ROMANI, DECONCINI & SYMMS 30792 WEDGEWOOD VILLAGE PHARMACY, INC. 2010 first_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. H.R. 3018, To amend the Controlled Substances Act to address the use of intrathecal pumps. Amends the Controlled Substances Act to revise the definition of "dispense" to include the delivery of a controlled substance through the use of an intrathecal pump by a practitioner acting in the usual course of professional practice. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2010-04-07T16:26:57.970000-04:00
908841 PARRY, ROMANI, DECONCINI & SYMMS b41d0f63-11f9-420c-910c-fb7443c4301e Q1 PARRY, ROMANI, DECONCINI & SYMMS 30792 WOMEN'S INTERNATIONAL PHARMACY, INC. 2010 first_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. H.R. 3018, To amend the Controlled Substances Act to address the use of intrathecal pumps. Amends the Controlled Substances Act to revise the definition of "dispense" to include the delivery of a controlled substance through the use of an intrathecal pump by a practitioner acting in the usual course of professional practice. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2010-04-07T16:34:59.313000-04:00
908845 PARRY, ROMANI, DECONCINI & SYMMS 63fbe3d2-22a6-4399-add6-e4c0f027d40e Q1 PARRY, ROMANI, DECONCINI & SYMMS 30792 YAVAPAI COLLEGE 2010 first_quarter PHA Support of funding to assist in the opening of a regional state university in Prescott, AZ as a joint venture between Yavapai Community College and Northern Arizona University. Support of grant proposal to provide funding for the training of allied health professionals. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2010-04-07T16:47:02.970000-04:00
909305 DUTKO WORLDWIDE, LLC aefcb527-ab7d-4945-9760-93cd6b338a6a Q1 DUTKO WORLDWIDE, LLC 12868 NEWAYS INTERNATIONAL 2010 first_quarter PHA Monitor legislation pertaining to dietary supplements and pharmaceuticals, particularly the Food Safety Modernization Act (S. 510). Affordable Health Care for America Act (H.R.3962), Patient Protection and Affordable Care Act (H.R.3590), America's Affordable Health Choices Act of 2009 (H.R.3200), Affordable Health Choices Act (S.1679), America's Healthy Future Act of 2009 (S.1796). Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2010-04-08T16:24:42-04:00
909503 MOFFETT GROUP, LLC 9749f972-02b1-4599-a20e-18a012b1ba0f 1T MOFFETT GROUP, LLC 82578 BOEHRINGER INGELHEIM PHARMECEUTICAL 2010 first_quarter PHA Phamaceutical issues, especially with respect to the House Energy and Commerce Committee. Our work is specifically related to the Connecticut delegation. HOUSE OF REPRESENTATIVES,SENATE 49578   0 1 2010-04-09T11:33:27.447000-04:00
909546 HANCE SCARBOROUGH 63ba0183-1782-4242-9ba9-09ad69cbabb3 Q1 HANCE SCARBOROUGH 17443 INTRATHECAL CUSTODY ACCOUNT SUPPORTERS (INFORMAL COALITION) 2010 first_quarter PHA Monitored legislation related to physician control and patient access to intrathecal pump applications for patients with chronic pain. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2010-04-09T12:32:22.647000-04:00
909574 HANCE SCARBOROUGH b6d6581c-9b9c-445e-a0b0-b6e2d9e54225 Q1 HANCE SCARBOROUGH 17443 TEXAS ACADEMY OF COMPOUNDING PHARMACISTS 2010 first_quarter PHA Federal legislation affecting the practice of pharmacy and FDA regulation of compounded drugs. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2010-04-09T13:10:33.023000-04:00
909630 SINGER CONSULTING LLC 36dc3a59-4b9c-457d-9dc4-d48c122878f8 Q1 SINGER CONSULTING LLC 74658 PFIZER INC. 2010 first_quarter PHA General corporate SENATE     0 0 2010-04-09T13:58:56.650000-04:00
909817 GREATER NEW YORK HOSPITAL ASSOCIATION 8cd7cb72-4957-4a06-a1a1-cbd79a24b4c2 Q1 GREATER NEW YORK HOSPITAL ASSOCIATION 16830 GREATER NEW YORK HOSPITAL ASSOCIATION 2010 first_quarter PHA Reducing the costs of pharmaceuticals, medical devices, and supplies for consumers and health care providers (various health care reform proposals (including the American Health Care Choices Act (S.1679); H.R.3962; H.R.3590); 340B Program Improvement and Integrity Act of 2009 (H.R. 444/S.1239)) Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),SENATE,White House Office   310000 0 0 2010-04-09T15:52:03.773000-04:00
909900 MEREDITH MCGEHEE 65cecffe-de78-4412-b595-bd07652903d8 Q1 MEREDITH MCGEHEE 79858 INTERNATIONAL AIDS VACCINE INITIATIVE 2010 first_quarter PHA Funding for program to develop AIDS vaccines targeted toward the developing world; Working with Global Health Technologies Coalition to educate on research and development programs aimed at the AIDS epidemic; Implementation of PEPFAR; Appropriations for USAID R&D and funding for IAVI; Providing information on "Protocol G" and the "Antibody Project" HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2010-04-09T18:26:25.380000-04:00
910394 AMERICAN COLLEGE OF CLINICAL PHARMACY c393ac44-579d-4ce2-a324-8363aa75cd88 Q1 AMERICAN COLLEGE OF CLINICAL PHARMACY 57258 AMERICAN COLLEGE OF CLINICAL PHARMACY 2010 first_quarter PHA Coverage for direct patient care services of qualified pharmacists under Medicare and other public health programs. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   54750 0 0 2010-04-12T14:34:19.143000-04:00
910479 HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) ae749dd3-7695-4962-ba37-5de3f9f6c643 Q1 HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) 28776 HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA) 2010 first_quarter PHA Importation of prescription drugs (S. 525/H.R. 1298), Import Safety (H.R. 759), Rx Pedigree, Counterfeit Drugs (H.R. 1450), Methamphetamine/Pseudoephedrine Regulation (S. 256), Pharmacy Benefit Management (PBM) issues (H.R. 4489) Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   190000 0 0 2010-04-12T15:58:23.313000-04:00
910673 HOLLAND & KNIGHT LLP 9d970ae0-4dda-48d1-9222-014398fded4c 1T HOLLAND & KNIGHT LLP 18466 BIOTECHNOLOGY INDUSTRY ORGANIZATION 2010 first_quarter PHA Issues relating to the biotechnology industry. HOUSE OF REPRESENTATIVES,SENATE 30000   0 1 2010-04-13T10:17:48.157000-04:00
911198 POLICY DIRECTIONS INC. 7bdcc95d-cc56-4395-8e02-0ae5554f9edf Q1 POLICY DIRECTIONS INC. 31747 ALPHARMA INC/PFIZER ANIMAL HEALTH (FORMERLY KNOWN AS ALPHARMA INC ) 2010 first_quarter PHA Antibiotics in animal foods Drug approvals Implementation of: All titles, to end the use of certain antibiotics in animal feed if those antibiotics are used in human medicine. S. 2313/HR3697, all titles, to require the manufacturers of antibiotics used in animal feed to make certain reports to FDA. Legislation to reform FDA regulation of federal imported and domestic food safety with emphasis on those titles related to the import of ingredients for food and drugs, as well as country-of-origin labeling. Monitor legislative and regulatory developments related to the Animal Drug User Fee Act reauthorization, with related developments of the Generic Animal Drug UserFee Act. Monitor developments of the Food & Drug Administrations development of its Advanced Feed Safety System related to the use of animal drugs in livestock and poultry feeds. Agriculture, Dept of (USDA),Energy, Dept of,Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2010-04-13T14:52:56.507000-04:00
911298 SQUIRE PATTON BOGGS dc17b3ce-0656-4c51-9cbc-77f031e80769 Q1 SQUIRE PATTON BOGGS 30906 SUNOVION PHARMACEUTICALS INC 2010 first_quarter PHA Advocacy regarding respiratory drug coverage and H.R. 3590. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2010-04-13T15:16:59.597000-04:00
911452 ANIMAL HEALTH INSTITUTE 09fb0915-3f76-4923-97bc-287daaff322c Q1 ANIMAL HEALTH INSTITUTE 4037 ANIMAL HEALTH INSTITUTE 2010 first_quarter PHA Antimicrobial Resistance; HR 1549, S619, Preservation of Antibiotics for Medical Treatment Act; HR2400, Strategies to Address Antimicrobial Resistance Act; S510, Food Safety Modernization Act; HR2749, Food Safety Enhancement Act of 2009; HR3590, Patient Protection and Affordable Care Act; HR 3962, Affordable Health Care for America Act. HOUSE OF REPRESENTATIVES,SENATE   30000 0 0 2010-04-13T16:03:59.087000-04:00
911780 WINBORN SOLUTIONS LLC dc85fa49-f94d-4d01-850f-6e6eb31a1b74 Q1 WINBORN SOLUTIONS LLC 308310 PERRIGO CO 2010 first_quarter PHA Dextromethorphan Distribution Act of 2009 Legislation to regulate the sale of psuedoephedrine Food and drug safety, user fee, and country of origin legislation HOUSE OF REPRESENTATIVES,SENATE 18000   0 0 2010-04-14T07:33:49.887000-04:00
912112 THE OB-C GROUP, LLC 3eda5ee3-98f5-4db9-b7db-657736456ac0 Q1 THE OB-C GROUP, LLC 29802 ELI LILLY 2010 first_quarter PHA HR 1548, Pathway for Biosimilars Act: entire bill. HR 4872, Health Care and Education Reconciliation Act of 2010: matters relating to pharmaceutical manufacturers in Health Care Reform including Biosimilars. HR 3590: Patient Protection and Affordable Care Act; matters relating to pharmaceutical manufacturers in Health Care Reform including Biosimilars. No specific bill number: matters relating to pharmaceutical manufacturers in Health Care Reform including Biosimilars. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2010-04-14T11:43:54.270000-04:00
912201 JOHNS HOPKINS UNIVERSITY cd46bb2e-5219-426a-b7e4-6798e45da6cd Q1 JOHNS HOPKINS UNIVERSITY 20664 JOHNS HOPKINS UNIVERSITY 2010 first_quarter PHA H.R. 444, 340B Program Improvement and Integrity Act of 2009. Extending 340B outpatient pharmaceutical discount to the inpatient setting. HOUSE OF REPRESENTATIVES,SENATE,White House Office   110000 0 0 2010-04-14T12:51:22.297000-04:00
913471 BOSE PUBLIC AFFAIRS GROUP d15cef6b-2c29-4ab9-919d-86f82beb3da5 Q1 BOSE PUBLIC AFFAIRS GROUP 297294 LILLY USA, LLC 2010 first_quarter PHA Healthcare Reform Bill - 340B Drug Program Extension HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2010-04-15T11:36:23.907000-04:00
913490 AMERICAN ADVERTISING FEDERATION deb32607-7f68-44aa-b9ca-ccbdd666f583 Q1 AMERICAN ADVERTISING FEDERATION 1411 AMERICAN ADVERTISING FEDERATION 2010 first_quarter PHA HR 3200, HR 3590, S 1679, S 1796, health care reform legislation as it affects the taxation or content of phamaceutical advertising HR 2175, to prohibit as indecent the broadcasting of any advertisement for a mediation for the treatment of erictile dysfunction Proposals to require a moratorium on the advertising of new prescription medications Proposals to extend Food and Drug Administration authority to advertising for over-the-counter medications Agriculture, Dept of (USDA),Centers For Disease Control & Prevention (CDC),Commerce, Dept of (DOC),Federal Communications Commission (FCC),Federal Trade Commission (FTC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE   30000 0 0 2010-04-15T11:41:33.533000-04:00
913770 BLUECROSS BLUESHIELD OF TENNESSEE e5106320-1eee-4af3-a483-2118d4a63d48 Q1 BLUECROSS BLUESHIELD OF TENNESSEE 6440 BLUECROSS BLUESHIELD OF TENNESSEE 2010 first_quarter PHA Biologicals S.623 E-Prescribing - Enhanced Health Care Value for All Act Comparative Effectiveness Research Act HOUSE OF REPRESENTATIVES,SENATE   40000 0 0 2010-04-15T12:42:25.470000-04:00
914108 APTIV, PLC 032f738d-0275-4046-90f7-2a1ff7801a5f Q1 APTIV, PLC 49054 APTIV PLC 2010 first_quarter PHA No activity this quarter Defense, Dept of (DOD),Energy, Dept of,Environmental Protection Agency (EPA),HOUSE OF REPRESENTATIVES,SENATE   71077 0 0 2010-04-15T14:45:13.220000-04:00
914146 SMITH GARSON FKA SMITH DAWSON & ANDREWS 2743c10f-725a-4660-895d-46648984dbe4 Q1 SMITH GARSON FKA SMITH DAWSON & ANDREWS 35707 PROSETTA CORPORATION 2010 first_quarter PHA Government Advertisement of Biopharmaceuticals SENATE     0 0 2010-04-15T14:47:41.277000-04:00
914151 SMITH GARSON FKA SMITH DAWSON & ANDREWS 9f8c9fa4-ac04-4d06-99b4-97728b8fee47 Q1 SMITH GARSON FKA SMITH DAWSON & ANDREWS 35707 STRUVE SWINE TECHNOLOGIES 2010 first_quarter PHA Government Advertisement of Biopharmaceuticals SENATE     0 0 2010-04-15T14:48:43.197000-04:00
914383 PODESTA GROUP, INC. efbb1541-59de-4b84-b72c-bc1286727c6f Q1 PODESTA GROUP, INC. 31680 BRISTOL-MYERS SQUIBB 2010 first_quarter PHA Drug Importation/Drug Safety H.R. 3590 Patient Protection and Affordable Care Act H.R. 4872 Health Care and Education Reconciliation Act of 2010 Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2010-04-15T15:30:01.533000-04:00
915768 BROWN RUDNICK LLP 78d48e61-e4c2-4152-8fa0-7c305a9af427 Q1 BROWN RUDNICK LLP 287895 HEALTHCARE DISTRIBUTION ALLIANCE F/K/A HEALTHCARE DISTRIBUTION MANAGEMENT ASSOC 2010 first_quarter PHA S.525 & S.1232- Pharmaceutical Market Access and Drug Safety Act of 2009 HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2010-04-16T11:09:55.747000-04:00
916015 INDEPENDENCE BLUE CROSS 627f2999-ee18-45d5-b17d-e929b8abcfee Q1 INDEPENDENCE BLUE CROSS 19172 INDEPENDENCE BLUE CROSS 2010 first_quarter PHA HR 4489 "To amend Chapter 89 of Title 5, United States Code, to ensure program integrity, transparency, and cost savings in the pricing and contracting of prescription drug benefits under the Federal Employees Health Benefit Program" HOUSE OF REPRESENTATIVES,SENATE     0 0 2010-04-16T11:51:08.807000-04:00
916110 NATIONAL ASSOCIATION OF CHAIN DRUG STORES a141e086-9217-4374-b8d0-4c2a3d873a8d Q1 NATIONAL ASSOCIATION OF CHAIN DRUG STORES 26672 NATIONAL ASSOCIATION OF CHAIN DRUG STORES 2010 first_quarter PHA H.R.3590, Patient Protection and Affordable Care Act H.R.4872: Reconciliation Act of 2010 H.R.616/S.511, Access to Durable Medical Equipment Act, related to the exemptionof pharmacies from Medicare accreditation requirements. H.R. 1970/S.956, Preserve Patient Access to Reputable DMEPOS Providers Act of 2009, as related to pharmacy exmpetion from Medicare Part B reguations. H.R.3108, the Medication Therapy Management Benefits Act, as related to expanded MTM services in the Medicare Part D program. H.R.3663, as related to the delay of pharmacy accreditation requirements under the Medicare DME program. H.R.3962, Affordable Health Care for America Act, as related to the role of pharmacy in healthcare reform, specifically in the Medicare and Medicaid programs. S. 256, Combat Methamphetamine Enhancement Act of 2009, as related to the abuse of methamphetamine. S. 1490, Personal Data Privacy and Security Act of 2009, as related to provider privacy requirements. H.R. 2221 Data Accountability and Trust Act, as related to provider privacy requirements. H.R. 4489, The Federal Employees Health Benefits Program (FEHBP) Prescription Drug Integrity, Transparency, and Cost Savings Act, as related to pharmacy participation, reimbursement, and dislosure requirements in the FEHBP. S. 3000, A bill to extend the increase in the FMAP provided in the American Recovery and Reinvestment Act of 2009 for an additional 6 months, as related to the increase in federal Medicaid matching funds. Centers For Medicare and Medicaid Services (CMS),Consumer Product Safety Commission (CPSC),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE,White House Office   470000 0 0 2010-04-16T12:06:20.230000-04:00
916495 UNIVERSITY OF CONNECTICUT 1439f478-bd11-4a08-9c6a-03acbc9482a7 Q1 UNIVERSITY OF CONNECTICUT 39382 UNIVERSITY OF CONNECTICUT 2010 first_quarter PHA Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2011, FDA salaries and expenses; and extramural research related issues. Agriculture, Dept of (USDA),HOUSE OF REPRESENTATIVES,Natl Oceanic & Atmospheric Administration (NOAA),SENATE,Small Business Administration (SBA)   70000 0 0 2010-04-16T13:50:26.057000-04:00
916535 INDEPENDENCE BLUE CROSS 07c355d0-2bba-48f6-b52f-abda2e2c528f 1A INDEPENDENCE BLUE CROSS 19172 INDEPENDENCE BLUE CROSS 2010 first_quarter PHA HR 4489 "To amend Chapter 89 of Title 5, United States Code, to ensure program integrity, transparency, and cost savings in the pricing and contracting of prescription drug benefits under the Federal Employees Health Benefit Program" HOUSE OF REPRESENTATIVES,SENATE     0 0 2010-04-16T14:02:22.373000-04:00
917891 MASSACHUSETTS BIOTECHNOLOGY COUNCIL 8a55e2b7-585a-4db1-bbe9-06fa768c3c75 Q1 MASSACHUSETTS BIOTECHNOLOGY COUNCIL 400271247 MASSACHUSETTS BIOTECHNOLOGY COUNCIL 2010 first_quarter PHA Legislation related to biosimilars Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Patent & Trademark Office (PTO),SENATE   10000 0 0 2010-04-17T15:02:59.723000-04:00
918374 AKIN GUMP STRAUSS HAUER & FELD a9119436-4fe0-4f85-b5bf-733e2f8aac30 Q1 AKIN GUMP STRAUSS HAUER & FELD 682 PRASCO, INC. 2010 first_quarter PHA Promoting consumer benefits of authorized generic drugs Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2010-04-18T13:25:22.750000-04:00
918392 WINSTON & STRAWN LLP 5ff7d90d-20d9-428b-b593-3023d4f5b439 Q1 WINSTON & STRAWN LLP 41682 WOCKHARDT USA LLC 2010 first_quarter PHA Generic drug issues HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2010-04-18T13:39:35.320000-04:00
918393 WINSTON & STRAWN LLP e87ca2d7-0633-473a-95f2-1e5a2367a9a3 Q1 WINSTON & STRAWN LLP 41682 ABRAXIS BIOSCIENCE LLC 2010 first_quarter PHA Issues related to safety of breast cancer drugs HOUSE OF REPRESENTATIVES,SENATE     0 0 2010-04-18T13:42:36.247000-04:00
918467 WINSTON & STRAWN LLP b7a8b199-1bb0-4507-aad9-f8793d1ad12f Q1 WINSTON & STRAWN LLP 41682 TEVA PHARMACEUTICALS USA 2010 first_quarter PHA Biogenerics HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2010-04-18T14:54:38.913000-04:00
918487 WINSTON & STRAWN LLP 37ca66db-34f9-4e6d-82c7-543b4c7ac544 Q1 WINSTON & STRAWN LLP 41682 FRESENIUS KABI USA (FORMERLY KNOWN AS APP PHARMACEUTICALS INC ) 2010 first_quarter PHA Represent the client on issues related to assuring a safe, reliable supply of heparin and also patent matters. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2010-04-18T15:41:02.220000-04:00
919367 POLICY ADVOCATES f3db1220-a850-4688-8306-05967bdbcba0 Q1 POLICY ADVOCATES 72018 PHOENIX CAPITAL MANAGEMENT LLC 2010 first_quarter PHA Track and monitor Internet Pharmacy Issues. HOUSE OF REPRESENTATIVES,SENATE 16500   0 0 2010-04-19T09:09:16.757000-04:00
919908 EISAI INC. 69de527b-fd7d-4a87-aca1-e2343a927b43 Q1 EISAI INC. 400321512 EISAI INC. 2010 first_quarter PHA Biosimilars (a.k.a follow-on biologics) S. 726 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 3590 Patient Protection and Affordable Care Act H.R. 4872 Health Care and Education reconciliation Act of 2010 Education, Dept of,HOUSE OF REPRESENTATIVES,SENATE   1370000 0 0 2010-04-19T10:36:36.413000-04:00
920032 WEXLER | WALKER, A UNIT OF HILL+KNOWLTON STRATEGIES, LLC e87ee4ed-a2c0-4d02-958f-2f89b2bba844 Q1 WEXLER | WALKER, A UNIT OF HILL+KNOWLTON STRATEGIES, LLC 41113 JARROW FORMULAS, INC. 2010 first_quarter PHA Federal food safety legislation affecting dietary supplements, and concerning Codex Alimentarius; S. 510 and the Dietary Supplement Health and Education Act Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2010-04-19T10:46:41.293000-04:00
920316 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 0a50872f-3979-48c6-9ada-d02bfe81f1e4 Q1 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 3457 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 2010 first_quarter PHA Communication with FDA regarding the quality of compounded drugs and improving stakeholder communications; Communications to the Agency for Healthcare Research and Quality regarding nominations to Effective Healthcare Stakeholder Group; Communication with FDA on Risk Evaluation and Mitigation Strategies and Prescription Drug User Fee Act Reauthorization Public Meeting. Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Environmental Protection Agency (EPA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   250000 0 0 2010-04-19T11:07:43.413000-04:00
920386 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 8894b1f2-e1aa-4c11-beaa-942fec297cf8 Q1 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 27478 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 2010 first_quarter PHA H.R. 1204, the "Community Pharmacy Fairness Act of 2009", and S. 2161 Community Pharmacy Fairness Act from the 110th Congress; H.R. 616 and S. 511, the "Access to Durable Medical Equipment Act of 2009"; H.R. 1970 and S. 956, the "Preserve Patient Access to Reputable DMEPOS Providers Act of 2009"; H.R. 6331 (110th Congress), the "Medicare Improvements for Patients and Providers Act of 2008." Sec. 154 related to Medicare DMEPOS competitive acquisition program; and Sec. 172, related to submission of claims by pharmacies located in or contracting with long-term care facilities; Sec. 203, related to pharmacy payment under Medicaid; H.R. 1, "American Recovery and Reinvestment Act - P.L. 111-5 -- provisions related to Health Information Technology and HIPPA requirements; H.R. 5839 of the 110th Congress, the "Safeguarding America's Pharmaceuticals Act of 2008", provision relating to pedigree and track and trace requirements; H.R. 1427, the "Promoting Innovation and Life Savings Medicines Act of 2009"; H.R. 2647 and S. 1390, National Defense Authorization Act for 2010-Provides for the funding for the Department of Defense for fiscal year 2010-including the Tricare pharmacy program; H.R. 3108, the "Medication Therapy Benefits Act of 2009"; S. 1649, the "Weapons of Mass Destruction (WMD) Prevention and Preparednesss Act of 2009, pharmacy provider provisions; S. 1383, the "Dextromethorphan Abuse Reduction Act; H.R.3663: To amend title XVIII of the Social Security Act to delay the date on which the accreditation requirement under the Medicare Program applies to suppliers of durable medical equipment that are pharmacies; H.R. 2891, the "Access to Frontline Health Care Act of 2009"; H.R. 3200, the "America's Affordable Health Choices Act of 2009"; the draft Senate HELP Committee's "Affordable Health Choices Act of 2009"; Senate Finance Committee draft health care reform bill, all provisions related to Medicaid AMP pharmacy reimbursement, Medicare Part B DMEPOS accreditation and surety bond requirements, medication therapy mana… Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Drug Enforcement Administration (DEA),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),SENATE,Small Business Administration (SBA),Treasury, Dept of   130000 0 0 2010-04-19T11:14:09.377000-04:00
920768 US STRATEGIES bf0df548-3536-4b57-9e72-01071dd419c2 Q1 US STRATEGIES 38825 NOVOLOGIX (FORMERLY ANCILLARY CARE MANAGEMENT) 2010 first_quarter PHA Medicare and Medicaid provisions relating to pharmacy and medication management policies HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2010-04-19T11:48:33.803000-04:00
920806 BUCHANAN INGERSOLL & ROONEY PC 268b43bb-7e41-40ef-81f0-bc636abf521b Q1 BUCHANAN INGERSOLL & ROONEY PC 55291 GENERIC ANIMAL DRUG ALLIANCE 2010 first_quarter PHA Legislative issues relating to United States Food & Drug Administration. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2010-04-19T11:53:01.503000-04:00
920820 PD FRAZER CONSULTING, INC. 0699cadd-c07c-4152-b237-712d309c0e19 Q1 PD FRAZER CONSULTING, INC. 65998 CANADA INTERNATIONAL PHARMACY ASSOCIATION 2010 first_quarter PHA Monitor the development of proposed bills about the importation of prescription drugs. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2010-04-19T11:54:56.773000-04:00
921153 THE DUBERSTEIN GROUP INC. 89cab30a-ed80-4aee-adfb-89eba32c6687 Q1 THE DUBERSTEIN GROUP INC. 12675 AMERICA'S HEALTH INSURANCE PLANS 2010 first_quarter PHA Generic biologics, generic prescription drugs - HR 3962, America's Affordable Health Choices Act. Generic biologics - HR 3590, Patient Protection and Affordable Care Act. Healthcare reform, including pharmaceutical issues - HR 4872, Health Care and Education Reconciliation Act of 2010. *Antitrust exemption for pharmacies - HR 1204, To ensure and foster continued patient safety and quality of care by making the antitrust laws apply to negotiations between groups of independent pharmacies and health plans and health insurance issuers (including health plans under parts C and D of the Medicare Program) in the same manner as such laws apply to protected activities under the National Labor Relations Act *Generic biologics - HR 1427, To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes; HR 1548, To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes; S 726, A bill to amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes; HR 3200, To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes; S 1679, An original bill to make quality, affordable health care available to all Americans, reduce costs, improve health care quality, enhance disease prevention, and strengthen the health care workforce. *Generic drugs - HR 1706, To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and for other purposes; S 369, A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market. *Prescription drug co-pays and formularies - S 1630, A bill to amend title XVIII of the Social Security Act of improve prescription drug coverage under Medicare part D and to amend t… HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE 100000   0 0 2010-04-19T12:26:37.040000-04:00
921521 REINECKE STRATEGIC SOLUTIONS, INC. 61304883-a59c-467a-aa5f-34efdfd20c36 Q1 REINECKE STRATEGIC SOLUTIONS, INC. 298012 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 2010 first_quarter PHA FY 2011 Appropriations for the Departments of Labor, Health and Human Services, Education and Related Agencies. Specifically for implementation of medication therapy management services program established in health care reform. H.R. 4489, the FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act. And generally, oversight of pharmacy benefits within the Federal Employees Health Benefits Plan (FEHBP) and other government programs. SENATE 10000   0 0 2010-04-19T13:10:15.037000-04:00
921557 MCDERMOTT WILL & SCHULTE LLP 94c169d9-71a8-4edd-aa51-0612d567e5d6 Q1 MCDERMOTT WILL & SCHULTE LLP 24338 ALLERGAN, INC. 2010 first_quarter PHA Issues related to Section 340B of the Public Health Service Act. Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE     0 0 2010-04-19T13:17:55.770000-04:00
921585 KAISER FOUNDATION HEALTH PLAN INC. 9069126e-4191-4083-92ed-003bbac1e0b0 Q1 KAISER FOUNDATION HEALTH PLAN INC. 21027 KAISER FOUNDATION HEALTH PLAN INC 2010 first_quarter PHA S 726 Promoting Innovation and Access to Life-Saving Medicine Act To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other products. Sponsor: Schumer (D-NY) HOUSE OF REPRESENTATIVES,SENATE   300000 0 0 2010-04-19T13:24:10.410000-04:00
921679 GILBERT'S LLP 13c7cb14-8528-4a8f-bda3-bef167825ce2 Q1 GILBERT'S LLP 67876 MYLAN LABORATORIES INC 2010 first_quarter PHA Reform to legislation and regulations affecting pharmaceutical drug approval and marketing Federal Trade Commission (FTC),SENATE 105000   0 0 2010-04-19T13:31:54.473000-04:00
922044 MCDERMOTT WILL & SCHULTE LLP d3bb8a06-780c-4251-9a59-90d8a9084230 Q1 MCDERMOTT WILL & SCHULTE LLP 24338 RURAL REFERRAL CENTER/SOLE COMMUNITY HOSPITAL COALITION 2010 first_quarter PHA Amendments to Section 340B of the Public Health Service Act to gain eligibility for rural referral centers and sole community hospitals in the federal discount drug purchasing program; seeking to advance H.R. 444, H.R. 3590 Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2010-04-19T14:02:22.693000-04:00
922048 VAN NESS FELDMAN, LLP ed2d33e1-6795-4e5b-b35b-83495829e334 Q1 VAN NESS FELDMAN, LLP 39815 MCKESSON CORPORATION 2010 first_quarter PHA H.R. 3590, Patient Protection and Affordable Care Act H.R. 4872, Health Care and Education Reconciliation Act of 2010 H.R. 3108, Medication Therapy and Management Benefits Act of 2009 S. 80, Pharmaceutical Market Access Act of 2009 S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009 Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2010-04-19T14:02:24.990000-04:00
922362 OGR 7986a7e2-479b-4a28-b26f-8e963e2e70be Q1 OGR 48827 SANOFI PASTEUR 2010 first_quarter PHA vaccine related issues HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2010-04-19T14:29:52.973000-04:00
922448 APOTEX CORP. e7d63d86-ee61-4dc3-a3aa-e29f4d3dfc86 Q1 APOTEX CORP. 310973 APOTEX CORP. 2010 first_quarter PHA S. 369, the Preserve Access to Affordable Pharmaceuticals Act S. 1315, the Drug Price Competition Act of 2009 H.R. 3777, the Drug Price Competition Act of 2009 H.R. 3962, Affordable Health Care for America Act, Section 2573, Protecting Consumer Access to Generic Drugs Act H.R. 3962, Affordable Heatlh Care for America Act, Section 2375, Licensure Pathway for Biosimilar Products H.R. 3590, the Patient Protection and Affordable Care Act, Title VII, Subtitle A, Biologics Price Competition and Innovation H.R. 4872, the Health Care and Education Reconciliation Act of 2010 pertaining to patent settlements between brand and generic pharmaceutical manufacturers Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,SENATE   130000 0 0 2010-04-19T14:40:28.737000-04:00
922581 THEODOSIOU CONSULTANTS bc6ac23b-925c-4910-a48d-6a1ca1cd469b Q1 THEODOSIOU CONSULTANTS 54621 THEODOSIOU CONSULTANTS 2010 first_quarter PHA S. 641 HOUSE OF REPRESENTATIVES,SENATE     0 0 2010-04-19T14:53:21.457000-04:00
922686 AMERICAN HEALTH CARE ASSOCIATION 82043717-c458-48b4-868c-6b08e46bcaaf Q1 AMERICAN HEALTH CARE ASSOCIATION 2491 AMERICAN HEALTH CARE ASSOCIATION 2010 first_quarter PHA Updating controlled sustances regulations for long-term care. Bureau of Citizenship & Immigration Services (BCIS),Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),SENATE   460000 0 0 2010-04-19T14:59:47.753000-04:00
922896 UNIVERSITY OF KANSAS 30e4bad5-5459-4ed7-bf33-b22d2c37d9b7 Q1 UNIVERSITY OF KANSAS 321373 UNIVERSITY OF KANSAS 2010 first_quarter PHA Provide briefing on KU School of Pharmacy research agenda and Institute for Advancing Medical Innovation; discuss invitation to federal officials with regulatory authority over pharmaceuticals Army, Dept of (Other),Education, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Joint Chiefs of Staff,Office of Science & Technology Policy (OSTP),President of the U.S.,SENATE   88550 0 0 2010-04-19T15:17:38.617000-04:00
923085 AARP 27e6c014-95dc-42de-b5de-daa95db2d9e9 Q1 AARP 1694 AARP 2010 first_quarter PHA S.525/H.R.1298/S.1232, Pharmaceutical Market Access and Drug Safety Act of 2009 - Discussed legislation which would create a system of safe importation of prescription drugs from abroad. S.726/H.R.1427, Promoting Innovation and Access to Life-Saving Medicine Act - Discussed legislation which would create a pathway for the approval of safe, effective biosimilar and generic biologic drugs. H.R.1706, Protecting Consumer Access to Generic Drugs Act of 2009 - Discussed legislation that would prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and for other purposes. S. 369, Preserve Access to Affordable Generics Act - Discussed legislation that would prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market,and for other purposes. S.515/H.R.1260/S.610, Patent Reform Act of 2009 - Discussed legislation that would amend federal patent law to rewrite provisions concerning the conditions for patentability. Specifically, AARP weighed in on the inequitable conduct provisions of the legislation. S. 301, Physician Payments Sunshine Act of 2009 - Discussed legislation that would provide for disclosure of gifts given by pharmaceutical and device manufacturers to physicians. S.1315, Federal Food, Drug and Cosmetic Act Amendment/H.R.3777 Drug Price Competition Act - Lobbied to expand the definition of "first applicant" under such Act to allow a generic drug manufacturer that is currently considered an applicant subsequent to a brand-name manufacturer's 180-day exclusivity period to qualify as a first applicant for purposes of filing an abbreviated application for a new drug. Requires such applicant ot submit a substantially complete application that contains and lawfully maintains a certification for such drug. H.R. 3200 America's Affordable Health Choices Act/S. 1679, Americas Health Choices Act/S.1796, America's Healthy Future Act - Discussed need for affordable quality healthcar… Administration on Aging,Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Energy, Dept of,Federal Communications Commission (FCC),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Internal Revenue Service (IRS),Labor, Dept of (DOL),Office of Management & Budget (OMB),Office of Personnel Management (OPM),Office of the Vice President of the United States,Securities & Exchange Commission (SEC),SENATE,Social Security Administration (SSA),Transportation, Dept of (DOT),Treasury, Dept of,White House Office   3970000 0 0 2010-04-19T15:28:39.583000-04:00
923204 AARP 3275a758-2fa5-452d-becf-3adcccbfdc7d 1A AARP 1694 AARP 2010 first_quarter PHA S.525/H.R.1298/S.1232, Pharmaceutical Market Access and Drug Safety Act of 2009 - Discussed legislation which would create a system of safe importation of prescription drugs from abroad. S.726/H.R.1427, Promoting Innovation and Access to Life-Saving Medicine Act - Discussed legislation which would create a pathway for the approval of safe, effective biosimilar and generic biologic drugs. H.R.1706, Protecting Consumer Access to Generic Drugs Act of 2009 - Discussed legislation that would prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and for other purposes. S. 369, Preserve Access to Affordable Generics Act - Discussed legislation that would prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market,and for other purposes. S.515/H.R.1260/S.610, Patent Reform Act of 2009 - Discussed legislation that would amend federal patent law to rewrite provisions concerning the conditions for patentability. Specifically, AARP weighed in on the inequitable conduct provisions of the legislation. S. 301, Physician Payments Sunshine Act of 2009 - Discussed legislation that would provide for disclosure of gifts given by pharmaceutical and device manufacturers to physicians. S.1315, Federal Food, Drug and Cosmetic Act Amendment/H.R.3777 Drug Price Competition Act - Lobbied to expand the definition of "first applicant" under such Act to allow a generic drug manufacturer that is currently considered an applicant subsequent to a brand-name manufacturer's 180-day exclusivity period to qualify as a first applicant for purposes of filing an abbreviated application for a new drug. Requires such applicant ot submit a substantially complete application that contains and lawfully maintains a certification for such drug. H.R. 3200 America's Affordable Health Choices Act/S. 1679, Americas Health Choices Act/S.1796, America's Healthy Future Act - Discussed need for affordable quality healthcar… Administration on Aging,Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Energy, Dept of,Federal Communications Commission (FCC),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Internal Revenue Service (IRS),Labor, Dept of (DOL),Office of Management & Budget (OMB),Office of Personnel Management (OPM),Office of the Vice President of the United States,Securities & Exchange Commission (SEC),SENATE,Social Security Administration (SSA),Transportation, Dept of (DOT),Treasury, Dept of,White House Office   3970000 0 0 2010-04-19T15:35:47.317000-04:00
923731 PODESTA GROUP, INC. 1ef724fd-ea01-4fe6-a4bb-3b258574b597 Q1 PODESTA GROUP, INC. 31680 EISAI INC. 2010 first_quarter PHA S. 726 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 3590 Patient Protection and Affordable Care Act H.R. 4872 Health Care and Education Reconciliation Act of 2010 HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2010-04-19T16:07:11.940000-04:00
923762 THE DUBERSTEIN GROUP INC. 4f846afd-7f85-4534-838f-43497532f14b Q1 THE DUBERSTEIN GROUP INC. 12675 NORVARTIS CORP 2010 first_quarter PHA Healthcare reform, including follow-on biologics and other pharmaceutical provisions - HR 3962, To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes; HR 3590, An act entitled The Patient Protection and Affordable Care Act; HR 4872, Health Care and Education Reconciliation Act of 2010. HOUSE OF REPRESENTATIVES,SENATE 100000   0 0 2010-04-19T16:09:21.160000-04:00
924048 THE DUBERSTEIN GROUP INC. d97beda2-2d66-4ca5-a511-a2a7bc8bdde2 Q1 THE DUBERSTEIN GROUP INC. 12675 SANOFI-AVENTIS U.S. INC. 2010 first_quarter PHA All aspects of healthcare reform, including pharmaceutical provisions - HR 3590, An act entitled The Patient Protection and Affordable Care Act; HR 3962, To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes; HR 4872, Health Care and Education Reconciliation Act of 2010. HOUSE OF REPRESENTATIVES,SENATE 100000   0 0 2010-04-19T16:30:22.987000-04:00
924221 MEHLMAN CONSULTING, INC. a107e0fa-c219-4097-8676-5db72c0d5a08 Q1 MEHLMAN CONSULTING, INC. 284950 ABBOTT LABORATORIES 2010 first_quarter PHA S. 1796, America's Healthy Future Act of 2009; H.R. 3200, America's Affordable Health Choices Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act. H.R. 4872, The Health Care and Education Reconciliation Act of 2010. FDA reforms; Medicare coverage and reimbursement. Follow on Biologics: H.R.1548, Pathway for Biosimilars Act. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2010-04-19T16:43:41.100000-04:00
924640 PODESTA GROUP, INC. 961f0068-8824-4653-88f3-0e66140402da Q1 PODESTA GROUP, INC. 31680 EMD SERONO INC 2010 first_quarter PHA H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 Pathway for Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act Drug Importation H.R. 1298 Pharmaceutical Market Access and Drug Safety Act of 2009 S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009 S. 1232 Pharmaceutical Market Access and Drug Safety Act of 2009 H.R. 2892 Department of Homeland Security Appropriations Act, 2010 (Drug Importation Issues) H.R. 3288 Consolidated Appropriations Act, 2010 (Drug Importation Issues) H.R. 2997 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2010 (Drug Importation Issues) HOUSE OF REPRESENTATIVES,Patent & Trademark Office (PTO),SENATE 60000   0 0 2010-04-19T17:08:55.883000-04:00
924728 EXPRESS SCRIPTS, INC. 98b831b0-7b9d-4a2b-a0cf-4295ecba2c59 Q1 EXPRESS SCRIPTS, INC. 294416 EXPRESS SCRIPTS, INC. 2010 first_quarter PHA Items related to reverse settlement payments between manufacturers--HR 1706, S 369 Policies related to the Federal Employees Health Benefit program's pharmacy benefit program--HR 4489 Design and coverage of pharmacy benefits in health reform legislation as well as PBM disclosure requirements--HR 3590, HR 4872 Policies related to restricting PBMs' ability to manage prescription drug benefits -- HR 4199 Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Trade Commission (FTC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office   380000 0 0 2010-04-19T17:13:29.960000-04:00
924777 BLUE CROSS AND BLUE SHIELD ASSOCIATION cf00b465-a86a-41ea-9368-919f8cfca7a3 Q1 BLUE CROSS AND BLUE SHIELD ASSOCIATION 6358 BLUE CROSS AND BLUE SHIELD ASSOCIATION 2010 first_quarter PHA HR 4489 "To amend Chapter 89 of Title 5, United States Code, to ensure program integrity, transparency, and cost savings in the pricing and contracting of prescription drug benefits under the Federal Employees Health Benefit Program" HOUSE OF REPRESENTATIVES,SENATE   1800000 0 0 2010-04-19T17:16:50.727000-04:00
925057 CUBIST PHARMACEUTICALS, INC. c19b66f3-5b5f-4050-93cc-2e8db1e8838b Q1 CUBIST PHARMACEUTICALS, INC. 40026226 CUBIST PHARMACEUTICALS 2010 first_quarter PHA Medical Research Prescription Drug/Federal Drug Admin/Center for Disease Control/Health and Human Services Issues Antibiotic Resistance Issues H.R. 2400 Strategies to Address Antimicrobial Resistance Act (STAAR) H.R. 2937 MRSA Infection Prevention and Patient Protection Act S. 369 Preserve Access to Affordable Generics Act of 2009 Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE   150000 0 0 2010-04-19T17:36:11.717000-04:00
925280 PODESTA GROUP, INC. 9dc526f6-b521-42dc-9a65-8e65120cffee Q1 PODESTA GROUP, INC. 31680 NOVO NORDISK INC 2010 first_quarter PHA Drug Importation H.R. 3590 Patient Protection and Affordable Care Act H.R. 4872 Health Care and Education Reconciliation Act of 2010 Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 60000   0 0 2010-04-19T17:51:45.553000-04:00
925340 FOLEY & LARDNER LLP d68ce6f4-f116-4ccf-8bca-80a8de856433 Q1 FOLEY & LARDNER LLP 15042 ROMARK LABORATORIES, LC 2010 first_quarter PHA Sale of new anti-viral drug Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2010-04-19T17:56:03.477000-04:00
925431 AMYLIN PHARMACEUTICALS f3ed38ac-ae6a-4b5b-9947-5e0c6aaf89b2 Q1 AMYLIN PHARMACEUTICALS 308536 AMYLIN PHARMACEUTICALS 2010 first_quarter PHA Physician Payments Sunshine provision of HR 3590 the Patient Protection and Affordable Care Act and H.R.4872 the Health Care and Education Reconciliation Act of 2010 FDA Risk Evaulation Mitigation Strategies (REMS) Drug Safety Communications Drug importation issues in HR 3590 the Patient Protection and Affordable Care Act and H.R.4872 the Health Care and Education Reconciliation Act of 2010 HOUSE OF REPRESENTATIVES,SENATE   320000 0 0 2010-04-19T18:02:38.087000-04:00
925698 WINNING STRATEGIES WASHINGTON 2bd02194-47ef-4438-a63d-ed44b6f55aac 1T WINNING STRATEGIES WASHINGTON 50796 DIABETES ACCESS TO CARE COALITION (DACC) 2010 first_quarter PHA Medicare, Durable Equipment, Prosthetics, Orthotics and Supplies-Competitive Bidding Program Issues H.R. 3590 Patient Protection and Affordable Care Act- H.R. 616 Pharmacists Exemption to CMS DME Requirements H.R. 3790 Repeal of Medicare Competitive Acquisition Program for DMEPOS Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 1 2010-04-19T18:32:22.820000-04:00
925734 PODESTA GROUP, INC. 40d7e3a3-73e6-4490-83c6-51307b3c3f1f 1T PODESTA GROUP, INC. 31680 WINNING STRATEGIES WASHINGTON LLC 2010 first_quarter PHA Medicare, Durable Equipment, Prosthetics, Orthotics and Supplies - Competitive Bidding Program Issues S. 1679 Affordable Health Choices Act H.R. 3200 American Health Choices Act of 2009 Tri Caucus Healthcare Reform Bill S. 1796 Americas Healthy Future Act of 2009 H.R. 616 Pharmacists Exemption to CMS DME Requirements H.R. 3962 Affordable Health Care for America Act H.R. 3590 Patient Protection and Affordable Care Act H.R. 3790 Repeal Of Medicare Competitive Acquisition Program for DMEPOS Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 40000   0 1 2010-04-19T18:36:36.647000-04:00
926152 FLYNN & ASSOCIATES, INC. 3fea84e7-0749-476c-a5f3-bac462b2804d Q1 FLYNN & ASSOCIATES, INC. 15020 PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION 2010 first_quarter PHA Healthcare Reform Legislation Pharmaceutical Industry Employment Issues HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2010-04-19T20:31:14.367000-04:00
926276 WALMART INC. 24a2f725-c179-412a-9d2c-705299519959 Q1 WALMART INC. 40305 WALMART INC 2010 first_quarter PHA H.R. 3108, Medication Therapy Management; H.R. 1970, Pharmacy and Optical Medicare Part B Surety Bond H.R. 3590, Patient Protection and Affordable Care Act H.R. 4872, The Helath Care and Education Affordablity Reconciliation Act Agriculture, Dept of (USDA),Commerce, Dept of (DOC),Energy, Dept of,Environmental Protection Agency (EPA),Federal Energy Regulatory Commission (FERC),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Labor, Dept of (DOL),Natl Security Council (NSC),Office of Management & Budget (OMB),SENATE,State, Dept of (DOS),Treasury, Dept of,U.S. Trade Representative (USTR),White House Office   1930000 0 0 2010-04-19T21:15:14.727000-04:00
926398 WINNING STRATEGIES WASHINGTON 82cac48c-9cac-4251-832e-956981fbca86 Q1 WINNING STRATEGIES WASHINGTON 50796 MEDA PHARMACEUTICALS 2010 first_quarter PHA FDA Risk Evaluation and Mitigation Strategies HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2010-04-19T21:59:02.357000-04:00
926401 AVENUE SOLUTIONS 68fe5370-e013-4e3c-b7bc-feaec5331111 Q1 AVENUE SOLUTIONS 72111 UNITEDHEALTH GROUP INC 2010 first_quarter PHA HR 1204, Community Pharmacy Fairness Act - antitrust exemption for pharmacies; HR 1427, Promoting Innovation and Access to Life Saving Medicine Act - generic biologics; HR 1548, Pathway for Biosimilars Act - generic biologics; HR 3200, America's Affordable Health Choices Act - generic biologics; HR 3590, Patient Protection and Affordable Care Act - generic biologics; HR 3962, Affordable Health Care for America Act - generic biologics; S 369, Preserve Access to Affordable Generics Act - generic drugs; S 726, Promoting Innovation and Access to Life-Saving Medicine Act - generic biologics; S 1679, Affordable Health Choices Act - generic biologics Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2010-04-19T22:00:04.123000-04:00
926405 AVENUE SOLUTIONS dde5bf94-56f9-4e04-aae5-82e8eed764e8 Q1 AVENUE SOLUTIONS 72111 EXPRESS SCRIPTS INC 2010 first_quarter PHA HR 1204, Community Pharmacy Fairness Act - antitrust exemption for pharmacies; HR 1427, Promoting Innovation and Access to Life Saving Medicine Act - generic biologics; HR 1548, Pathway for Biosimilars Act - generic biologics; HR 1706, Protecting Consumer Access to Generic Drugs Act - generic drugs; HR 3200, America's Affordable Health Choices Act - medication therapy management, RDS (retiree prescription drug coverage), IVIG (intravenous immune globulin), transparency, data minimg, pharmaceutical benefit manager excise tax, generic biologics; HR 3590, Patient Protection and Affordable Care Act - medication therapy management, RDS (retiree prescription drug coverage), IVIG (intravenous immune globulin), transparency, data mining, pharmaceutical benefit manager excise tax, generic biologics; HR 3962, Affordable Health Care for America Act - medication therapy management, RDS (retiree prescription drug coverage), IVIG (intravenous immune globulin), transparency, data mining, pharmaceutical benefit manager excise tax, generic biologics, generic prescription drugs; HR 4489, FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act HR 4872, Health Care and Education Reconciliation Act - medication therapy management, RDS (retiree prescription drug coverage), IVIG (intravenous immune globulin), transparency, data mining, pharmaceutical benefit manager excise tax, generic biologics; S. 369, Preserve Access to Affordable Generics Act - generic drugs; S 726, Promoting Innovation and Access to Life-Saving Medicine Act - generic biologics; S 1630, Affordable Access to Prescription Medications Act - prescription drug co-pays and formularies; S 1679, Affordable Health Choices Act - medication therapy management, RDS (retiree prescription drug coverage), IVIG (intravenous immune globulin), transparency, data mining, pharmaceutical benefit manager excise tax, generic biologics; S 1796, American's Healthy Future Act - medication therapy management, RDS (retiree prescription drug coverage), IVIG (intrave… Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2010-04-19T22:02:05.403000-04:00
926417 AVENUE SOLUTIONS eb365541-24aa-45e2-b7a6-ad432bc9f271 Q1 AVENUE SOLUTIONS 72111 AETNA 2010 first_quarter PHA HR 1204, Community Pharmacy Fairness Act - antitrust exemption for pharmacies; HR 1427, Promoting Innovation and Access to Life Saving Medicine Act - generic biologics; HR 1548, Pathway for Biosimilars Act - generic biologics; HR 3200, America's Affordable Health Choices Act - generic biologics; HR 3590, Patient Protection and Affordable Care Act - generic biologics; HR 3962, Affordable Health Care for America Act - generic biologics; S 369, Preserve Access to Affordable Generics Act - generic drugs; S 726, Promoting Innovation and Access to Life-Saving Medicine Act - generic biologics; S 1679, Affordable Health Choices Act - generic biologics Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2010-04-19T22:05:10.777000-04:00
926422 AVENUE SOLUTIONS 6e046dce-fcd8-44ef-a8cc-204c390b4ffa Q1 AVENUE SOLUTIONS 72111 BLUE CROSS BLUE SHIELD ASSOCIATION 2010 first_quarter PHA HR 1204, Community Pharmacy Fairness Act - antitrust exemption for pharmacies; HR 1427, Promoting Innovation and Access to Life Saving Medicine Act - generic biologics; HR 1548, Pathway for Biosimilars Act - generic biologics; HR 3200, America's Affordable Health Choices Act - generic biologics; HR 3590, Patient Protection and Affordable Care Act - generic biologics; HR 3962, Affordable Health Care for America Act - generic biologics; S 369, Preserve Access to Affordable Generics Act - generic drugs; S 726, Promoting Innovation and Access to Life-Saving Medicine Act - generic biologics; S 1679, Affordable Health Choices Act - generic biologics Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2010-04-19T22:07:13.997000-04:00
926452 AVENUE SOLUTIONS c4e6a600-cdfe-43f8-a84d-630575a136e2 Q1 AVENUE SOLUTIONS 72111 HEALTHCARE LEADERSHIP COUNCIL 2010 first_quarter PHA HR 1204, Community Pharmacy Fairness Act - antitrust exemption for pharmacies; HR 1427, Promoting Innovation and Access to Life Saving Medicine Act - generic biologics; HR 1548, Pathway for Biosimilars Act - generic biologics; HR 3200, America's Affordable Health Choices Act - generic biologics; HR 3590, Patient Protection and Affordable Care Act - generic biologics; HR 3962, Affordable Health Care for America Act - generic biologics; S 369, Preserve Access to Affordable Generics Act - generic drugs; S 726, Promoting Innovation and Access to Life-Saving Medicine Act - generic biologics; S 1679, Affordable Health Choices Act - generic biologics Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2010-04-19T22:18:25.763000-04:00
926469 CAPITOL HILL CONSULTING GROUP 69576bc2-d3b3-4d15-be04-f2e3a89cba89 Q1 CAPITOL HILL CONSULTING GROUP 72053 PURDUE PHARMA LLP 2010 first_quarter PHA Controlled Drug Substances Act (21 USC 13) HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2010-04-19T22:29:33.060000-04:00
926798 VAN SCOYOC ASSOCIATES 26cdc2d0-6974-4d9e-9a02-deada296dc77 Q1 VAN SCOYOC ASSOCIATES 39837 UNIVERSITY OF CONNECTICUT 2010 first_quarter PHA Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2011, FDA salaries and expenses; and extramural research related issues. Agriculture, Dept of (USDA),HOUSE OF REPRESENTATIVES,Natl Oceanic & Atmospheric Administration (NOAA),SENATE,Small Business Administration (SBA) 40000   0 0 2010-04-20T06:12:32.220000-04:00
926812 VAN SCOYOC ASSOCIATES 73ee2d97-0c9f-4c85-8835-285ebcf15d02 Q1 VAN SCOYOC ASSOCIATES 39837 UNIVERSITY OF MARYLAND BALTIMORE 2010 first_quarter PHA No lobbying activity. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2010-04-20T06:13:35.220000-04:00
926822 VAN SCOYOC ASSOCIATES 0cae37f9-c1d5-4eea-bb7a-654c1784d903 Q1 VAN SCOYOC ASSOCIATES 39837 UNIVERSITY OF PENNSYLVANIA SCHOOL OF MEDICINE 2010 first_quarter PHA Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2011, FDA and USDA funding initiatives; Critical Path Partnership. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2010-04-20T06:14:37.377000-04:00
927243 ASSOCIATION FOR ACCESSIBLE MEDICINES 40b34380-7a6e-4d61-9dd0-8cb0ef733991 Q1 ASSOCIATION FOR ACCESSIBLE MEDICINES 16032 ASSOCIATION FOR ACCESSIBLE MEDICINES 2010 first_quarter PHA Generic Biologics, Health Care Reform, Budget Reconciliation, Prescription Drug Safety, Counterfeit Drugs/Import Safety/Pedigree, Authorized Generics, Prescription Drug Importation/Re-Importation, 340B Drug Pricing Program, and generic drugs H.R.1427 and S.726 - Promoting Innovation and Access to Life-Saving Medicines Act, all provisions H.R.1548 - Pathway for Biosimilars Act, all provisions H.R.573, all provisions S.501 - Fair Prescription Drug Competition Act, all provisions S.882 - Drug and Device Accountability Act of 2009, Title I Subtitle A, B, C, and D and Title II H.R. 759 - Food and Drug Administration Globalization Act of 2009, Title II S.525, S.1232, and H.R.1298 - Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.3590 - Patient Protection and Affordable Care Act, Title VII - Improving Access to Innovative Medical Therapies; Section 10609 Generic Drug Labeling H.R.3962 - Affordable Health Care for America Act, Title I Subtitle B Part 3 Section 1149A - Payment for Biosimilar Biological Products; Title V Subtitle C Part 2 - Biosimilars H.R.4872 - Reconciliation Bill, Section 1101, Closing the Medicare Prescription Drug "Donut Hole" Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Congressional Budget Office (CBO),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,U.S. Trade Representative (USTR),White House Office   679260 0 0 2010-04-20T09:07:24.817000-04:00
927306 VENABLE LLP db93eede-38de-4e21-a9bf-0af14eb087b1 Q1 VENABLE LLP 39941 ENDO PHARMACEUTICALS INC 2010 first_quarter PHA General issues affecting the pharmaceutical industry HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2010-04-20T09:13:52.303000-04:00
927470 K&L GATES, LLP 0a93b96d-1576-4691-b38c-acbd9927f294 Q1 K&L GATES, LLP 32098 ABRAXIS BIOSCIENCE, INC. 2010 first_quarter PHA H.R. 3962 the Affordable Health Care for America Act; H.R. 3590 Senate Leadership's Health Care Overhaul: issues related to the regulation of biologics. HOUSE OF REPRESENTATIVES,SENATE 90000   0 0 2010-04-20T09:25:06.067000-04:00
927662 AMERICAN VETERINARY MEDICAL ASSOCIATION 2833592e-188f-4af7-9add-71cee42b9f9d Q1 AMERICAN VETERINARY MEDICAL ASSOCIATION 3630 AMERICAN VETERINARY MEDICAL ASSOCIATION 2010 first_quarter PHA S 619/HR 1549, Preservation of Antibiotics for Medical Treatment Act Agriculture, Dept of (USDA),Commerce, Dept of (DOC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   160000 0 0 2010-04-20T09:39:38.317000-04:00
927711 TARPLIN, DOWNS & YOUNG, LLC b79f3a2b-dd4e-4f09-a348-304291b469e9 Q1 TARPLIN, DOWNS & YOUNG, LLC 304736 HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) 2010 first_quarter PHA **see addendum page Importation of prescription drugs (S. 525/H.R. 1298) RX Pedigree Import Safety (H.R. 759) Counterfeit Drugs (H.R. 1450) Methamphetamine / Pseudoephedrine Regulation (S. 256) Dextromethorphan Regulation (H.R. 1259) Pharmacy Benefit Management Issues (H.R. 4489) HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2010-04-20T09:42:57.507000-04:00
928011 THE PROCTER AND GAMBLE COMPANY 1502f4ac-6810-41a1-afa2-9707b7f3049b Q1 THE PROCTER AND GAMBLE COMPANY 32225 THE PROCTER AND GAMBLE COMPANY 2010 first_quarter PHA H.R. 1359 Secure and Responsible Drug Disposal Act of 2009; H.R. 1191 Safe Drug Disposal Act of 2009; H.R.1259 Dextromethorphan Distribution Act of 2009; S. 1383 Dextromethorphan Abuse Reduction Act of 2009; S. 256 Combat Methamphetamine Enhancement Act of 2009 Bureau of Citizenship & Immigration Services (BCIS),Commerce, Dept of (DOC),Consumer Product Safety Commission (CPSC),Energy, Dept of,Environmental Protection Agency (EPA),Executive Office of the President (EOP),Federal Communications Commission (FCC),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Intl Trade Administration (ITA),Justice, Dept of (DOJ),Natl Security Council (NSC),Office of Science & Technology Policy (OSTP),Patent & Trademark Office (PTO),SENATE,State, Dept of (DOS),Treasury, Dept of,U.S. Agency for International Development (USAID),U.S. Customs & Border Protection,U.S. Immigration & Customs Enforcement (ICE),U.S. International Trade Commission (ITC),U.S. Trade Representative (USTR)   1046127 0 0 2010-04-20T10:04:18.417000-04:00

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);
Powered by Datasette · Queries took 1702.746ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API